
Keywords: AAR; area at risk; AP; agonist peptide; Cat.G; cathepsin G; cTnI; cardiac troponin I; EGFR; epidermal growth factor receptor; IA; infarct area; IR; ischemia-reperfusion; KO; knockout; LAD; left anterior descending; LV; left ventricular; MPO; myeloperoxi